Rittirsch Daniel, Flierl Michael A, Day Danielle E, Nadeau Brian A, McGuire Stephanie R, Hoesel Laszlo M, Ipaktchi Kyros, Zetoune Firas S, Sarma J Vidya, Leng Lin, Huber-Lang Markus S, Neff Thomas A, Bucala Richard, Ward Peter A
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
J Immunol. 2008 Jun 1;180(11):7664-72. doi: 10.4049/jimmunol.180.11.7664.
Although acute lung injury (ALI) is an important problem in humans, its pathogenesis is poorly understood. Airway instillation of bacterial LPS, a known complement activator, represents a frequently used model of ALI. In the present study, pathways in the immunopathogenesis of ALI were evaluated. ALI was induced in wild-type, C3(-/-), and C5(-/-) mice by airway deposition of LPS. To assess the relevant inflammatory mediators, bronchoalveolar lavage fluids were evaluated by ELISA analyses and various neutralizing Abs and receptor antagonists were administered in vivo. LPS-induced ALI was neutrophil-dependent, but it was not associated with generation of C5a in the lung and was independent of C3, C5, or C5a. Instead, LPS injury was associated with robust generation of macrophage migration inhibitory factor (MIF), leukotriene B(4) (LTB4), and high mobility group box 1 protein (HMGB1) and required engagement of receptors for both MIF and LTB4. Neutralization of MIF or blockade of the MIF receptor and/or LTB4 receptor resulted in protection from LPS-induced ALI. These findings indicate that the MIF and LTB4 mediator pathways are involved in the immunopathogenesis of LPS-induced experimental ALI. Most strikingly, complement activation does not contribute to the development of ALI in the LPS model.
尽管急性肺损伤(ALI)在人类中是一个重要问题,但其发病机制仍知之甚少。气道内滴注细菌脂多糖(LPS),一种已知的补体激活剂,是常用的ALI模型。在本研究中,评估了ALI免疫发病机制中的途径。通过气道内沉积LPS在野生型、C3(-/-)和C5(-/-)小鼠中诱导ALI。为了评估相关的炎症介质,通过ELISA分析评估支气管肺泡灌洗液,并在体内给予各种中和抗体和受体拮抗剂。LPS诱导的ALI依赖中性粒细胞,但与肺中C5a的产生无关,且不依赖于C3、C5或C5a。相反,LPS损伤与巨噬细胞移动抑制因子(MIF)、白三烯B4(LTB4)和高迁移率族蛋白B1(HMGB1)的大量产生有关,并且需要MIF和LTB4的受体参与。中和MIF或阻断MIF受体和/或LTB4受体可保护小鼠免受LPS诱导的ALI。这些发现表明,MIF和LTB4介质途径参与了LPS诱导的实验性ALI的免疫发病机制。最引人注目的是,补体激活在LPS模型中对ALI的发展没有作用。